Biological and Clinical Underpinnings of Postoperative Pain - Colorectal Surgery
BAC-UPP 2
2 other identifiers
observational
128
0 countries
N/A
Brief Summary
Persistent pain after colorectal surgery remains a significant clinical challenge that can delay recovery, reduce quality of life, and increase long-term healthcare burden. The goal of this study is to gain a deeper understanding of the biological and clinical factors that influence pain severity after colorectal surgery and contribute to the transition from acute to chronic postoperative pain. Guided by a biopsychosocial framework, this research will address the following aims:
- 1.The investigators will use standardized experimental pain testing before surgery to evaluate how patients respond to different types of controlled sensory stimuli. These responses may help predict who is more likely to experience severe or prolonged pain after surgery.
- 2.The investigators will analyze blood samples collected before and after surgery to measure markers of inflammation and other biological responses. These data will help us explore how the body's immune and hormonal systems relate to pain severity in both the short- and longer-term recovery phases.
- 3.The investigators will assess psychological and clinical factors, such as emotional health, coping style, household income, and life stressors, to understand how they contribute to patients' pain experiences throughout recovery.
- 4.The investigators will examine whether routinely collected demographic and clinical characteristics can help identify patients at greater risk of experiencing higher levels of pain after surgery. This approach will allow us to better understand which patients may benefit from more tailored perioperative pain management strategies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2026
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 17, 2025
CompletedFirst Posted
Study publicly available on registry
October 21, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2030
March 13, 2026
March 1, 2026
2.3 years
October 17, 2025
March 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Chronic Pain after colorectal surgery
Pain Measured 3 months following colorectal surgery using the Brief Pain Inventory (BPI) pain score is a 0-40 score with higher scores reflecting more pain. Questions 3-6 are scored on 0-10 and are summed to provide an overall pain score. Change scores will be calculated.
12 weeks after surgery
Acute Pain after Surgery
Pain rating 48 hours after surgery using the Brief Pain Inventory (BPI) pain score is a 0-40 score with higher scores reflecting more pain. Questions 3-6 are scored on 0-10 and are summed to provide an overall pain score. Change scores will be calculated.
48 hours after surgery
Study Arms (1)
Colorectal Surgery Patients
Patients undergoing colorectal surgery
Eligibility Criteria
Patients scheduled to undergo colorectal surgery
You may qualify if:
- Participants scheduled for colorectal cancer surgery
- Age between 18-65; 3)
- Understanding verbal and written English
You may not qualify if:
- Concurrent medical conditions that could confound the interpretation of the data
- Human immunodeficiency virus positive diagnosis
- Cardiovascular or pulmonary disease
- Systemic rheumatoid disease
- Uncontrolled hypertension (i.e. SBP/DBP of \> 150/95
- Current illness accompanied by fever (body temperature \>38 °C)
- Any other chronic pain conditions
- Conditions resulting in altered nerve sensation
- Hospitalization due to psychiatric illness within the last 6 months
- Poorly controlled diabetes
- History of stroke
- History of seizures
- Circulatory disorders such AS Raynauds' disease
- History of drug or alcohol abuse.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (8)
Bruce J, Quinlan J. Chronic Post Surgical Pain. Rev Pain. 2011 Sep;5(3):23-9. doi: 10.1177/204946371100500306.
PMID: 26526062BACKGROUNDKatz J, Seltzer Z. Transition from acute to chronic postsurgical pain: risk factors and protective factors. Expert Rev Neurother. 2009 May;9(5):723-44. doi: 10.1586/ern.09.20.
PMID: 19402781BACKGROUNDSmall C, Laycock H. Acute postoperative pain management. Br J Surg. 2020 Jan;107(2):e70-e80. doi: 10.1002/bjs.11477.
PMID: 31903595BACKGROUNDDobson GP. Trauma of major surgery: A global problem that is not going away. Int J Surg. 2020 Sep;81:47-54. doi: 10.1016/j.ijsu.2020.07.017. Epub 2020 Jul 29.
PMID: 32738546BACKGROUNDHorn R, Hendrix JM, Kramer J. Postoperative Pain Control. 2024 Jan 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK544298/
PMID: 31335018BACKGROUNDGan TJ. Poorly controlled postoperative pain: prevalence, consequences, and prevention. J Pain Res. 2017 Sep 25;10:2287-2298. doi: 10.2147/JPR.S144066. eCollection 2017.
PMID: 29026331BACKGROUNDOverstreet DS, Hollis RH. Achieving Health Equity: Advancing Colorectal Surgery among Racial and Ethnic Minorities in America. Clin Colon Rectal Surg. 2024 May 13;38(1):34-40. doi: 10.1055/s-0044-1786532. eCollection 2025 Jan.
PMID: 39734714BACKGROUNDOverstreet DS, Strath LJ, Sorge RE, Thomas PA, He J, Wiggins AM, Hobson J, Long DL, Meints SM, Aroke EN, Goodin BR. Race-specific associations: inflammatory mediators and chronic low back pain. Pain. 2024 Jul 1;165(7):1513-1522. doi: 10.1097/j.pain.0000000000003154. Epub 2024 Feb 6.
PMID: 38323608BACKGROUND
Biospecimen
Blood Specimen Collection: The following biomarkers: (proinflammatory) Fibrinogen, Serum Amyloid A, interleukin-1 alpha (IL-1α), 1IL-1β, IL-6, Tumor necrosis factor-alpha (TNF-α), and (Anti-inflammatory) Vitamin D, IL4, IL10, IFN-a will be determined by implementing the Meso Scale Discovery, which is an enzyme-linked immunosorbent assay (ELISA) that employs electrochemiluminescence to identify specific binding events.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Surgery
Study Record Dates
First Submitted
October 17, 2025
First Posted
October 21, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
August 31, 2028
Study Completion (Estimated)
August 1, 2030
Last Updated
March 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- Available 6 months after publication of primary results
- Access Criteria
- This data/information will be made available via email request
de-identified QST data, biomarkers, survey responses, demographics